Adjuvant Pembrolizumab and Survival in Renal-Cell Carcinoma | NEJM
Adjuvant pembrolizumab was approved for patients with renal-cell carcinoma on the basis of improvements in disease-free survival observed in the KEYNOTE-564 …
Adjuvant pembrolizumab was approved for patients with renal-cell carcinoma on the basis of improvements in disease-free survival observed in the KEYNOTE-564 …
Sol Rashidi, author of ‘Your AI Survival Guide,’ says successful AI deployment requires strategic vision, leadership, and innovation culture.
The collection of data and study of genomics to allow for a ‘hyper-personalised’ approach
Kick-ass coffee decaffeinated with Swiss Water® Process. The best of our blends: deep, dark, tip-top taste and a fine finish. Drink up and dream on!
Executives at CVS Health Aetna, Humana and UnitedHealth Group provided investors an outlook on their Medicare Advantage businesses.
AI may shore up an industry experiencing economic headwinds. But in a field where professional ethics and public trust are particularly important, it’s a risky…
Solar panels will be the main source of renewable energy in 2030, and they’re mostly made in China. For the United States, the accelerating pace…
In this week’s Letters to the Editor, STAT readers respond to H5N1 and livestock movements, insulin discontinuation, and more.
Grünen Club-Chefin Petrovic an Seite von Dr. Hamer kontra Anzeiger Kinder-Prim. Dr. Jürgenssen
Snippet from a talk at the Educational Symposia -ESI Colorado meetings. Great annual meetings that combine 4h of CME per day with free time to…
A key driver of advances in childhood survival over the past half-century, the EPI faces fresh challenges in protecting the most vulnerable. Udani Samarasekera reports.